NEW YORK & COPENHAGEN, Denmark--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and Genmab A/S (Nasdaq: GMAB) announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results